---
title: "Top 10 HK Stock Gainers (3.27)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280752798.md"
description: "XUNCE(03317) rose 24.26%, with a trading turnover 2.2 Billion HKD, and a year-to-date rose 273.3%. NEW VISION CO(02632) rose 23.93%, with a trading turnover 36.2 Million HKD, and a year-to-date rose 31.2%. CSTONE PHARMA-B(02616) rose 20.72%, with a trading turnover 613.5 Million HKD, and a year-to-date rose 58.1%."
datetime: "2026-03-27T08:30:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280752798.md)
  - [en](https://longbridge.com/en/news/280752798.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280752798.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/280752798.md) | [繁體中文](https://longbridge.com/zh-HK/news/280752798.md)


# Top 10 HK Stock Gainers (3.27)

Hang Seng Index has rose 0.38%, with a year-to-date fell 2.6%; Hang Seng TECH Index has rose 0.35%, with a year-to-date fell 13.4%.

XUNCE(03317) rose 24.26%, with a trading turnover 2.2 Billion HKD, and a year-to-date rose 273.3%.

NEW VISION CO(02632) rose 23.93%, with a trading turnover 36.2 Million HKD, and a year-to-date rose 31.2%.

CSTONE PHARMA-B(02616) rose 20.72%, with a trading turnover 613.5 Million HKD, and a year-to-date rose 58.1%.

### Related Stocks

- [XUNCE (03317.HK)](https://longbridge.com/en/quote/03317.HK.md)
- [NEW VISION CO (02632.HK)](https://longbridge.com/en/quote/02632.HK.md)
- [CSTONE PHARMA-B (02616.HK)](https://longbridge.com/en/quote/02616.HK.md)
- [ZHOU HEI YA (01458.HK)](https://longbridge.com/en/quote/01458.HK.md)
- [LONKING (03339.HK)](https://longbridge.com/en/quote/03339.HK.md)
- [CSPC PHARMA (01093.HK)](https://longbridge.com/en/quote/01093.HK.md)
- [INSILICO (03696.HK)](https://longbridge.com/en/quote/03696.HK.md)
- [JOINN (06127.HK)](https://longbridge.com/en/quote/06127.HK.md)
- [DUALITYBIO-B (09606.HK)](https://longbridge.com/en/quote/09606.HK.md)
- [LEADS BIOLABS-B (09887.HK)](https://longbridge.com/en/quote/09887.HK.md)

## Related News & Research

- [InSilico Expands AI-Driven CNS Collaboration With Tenacia in USD94.75 Million Deal](https://longbridge.com/en/news/280541264.md)
- [CSPC Pharma's Profit Falls 10% in 2025; Misses EPS, Revenue Estimates](https://longbridge.com/en/news/280415449.md)
- [Tranche Update on CSPC Pharmaceutical Group Limited's Equity Buyback Plan announced on September 19, 2024.](https://longbridge.com/en/news/280502605.md)
- [CSPC Profit Slips but Dividend Rises as China Pharma Shifts to Innovation](https://longbridge.com/en/news/280418974.md)
- [InSilico Out-licensed Drug ISM4808 Begins Clinical Trial](https://longbridge.com/en/news/278010381.md)